List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Botulism - Overview
Botulism - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Botulism - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Botulism - Companies Involved in Therapeutics Development
AlphaVax Inc
CytoDel Inc
Hawaii Biotech Inc
Inventox Inc
Shield Pharma LLC
Botulism - Drug Profiles
bithionol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
botulinum vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
botulinum vaccine [serogroups A, A1, B and B1] - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
botulism [serotype C] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
botulism [serotypes A, B, E] (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cyto-111 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibodies to Inhibit Botulinum Neurotoxin Type A for Botulism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody to Inhibit Botulinum Neurotoxin E for Botulism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Botulinum Neurotoxin Type A for Botulism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Botulinum Toxin for Botulism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Botulism - Dormant Projects
Botulism - Discontinued Products
Botulism - Product Development Milestones
Featured News & Press Releases
Jan 07, 2021: CytoDel announces pre-clinical data on Cyto-111 as antidote to Botulinum Neurotoxin (BoNT) published in science translational medicine
Jan 24, 2012: DynPort Vaccine Announces Results For Phase II Botulinum Vaccine Clinical Trial
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Botulism, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Botulism - Pipeline by AlphaVax Inc, 2021
Botulism - Pipeline by CytoDel Inc, 2021
Botulism - Pipeline by Hawaii Biotech Inc, 2021
Botulism - Pipeline by Inventox Inc, 2021
Botulism - Pipeline by Shield Pharma LLC, 2021
Botulism - Dormant Projects, 2021
Botulism - Discontinued Products, 2021

List of Figures
Number of Products under Development for Botulism, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• AlphaVax Inc
• CytoDel Inc
• Hawaii Biotech Inc
• Inventox Inc
• Shield Pharma LLC
• Botulism - Drug Profiles
• bithionol - Drug Profile
• Product Description
• Mechanism Of Action
• R&D Progress